Academic program reviews (not associated with accreditation reviews) are to occur every 8 years according to a published timetable included in this document. Important characteristics of the academic ...

A Democratic lawmaker is raising new concerns about an FDA program designed to drastically shorten the review of certain drugs, including whether senior officials involved in the effort are complying ...

UTA officials identified some undergraduate and master’s degrees that could be cut as part of a review of programs underway at the university. Officials did not immediately detail which ones or how ...

WASHINGTON (AP) — A Democratic lawmaker raised new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials ...

A new Penn State University program is designed to help undergraduate students explore and navigate changing campuses. The university announced Monday it is launching “Penn State Pathways” this spring ...

Oklahoma Gov. Kevin Stitt has ordered a sweeping review of welfare programs, directing agencies to focus on fraud prevention and workforce participation. Gov. Kevin Stitt has signed an executive order ...

Will Democrats Be Able to Force Disclosure of Jack Smith’s Mar-a-Lago Report? Malign Regimes Keep Getting a Pass with the American Media Iran Chose the Hard Way Trump’s new federal school choice ...

Department of War Secretary Pete Hegseth said the Pentagon is reviewing the Small Business Administration’s 8(a) Business Development Program, arguing that the long-running initiative has strayed from ...

Homeland Security Secretary Kristi Noem confirmed Sunday that the agency is conducting an internal review of the actions taken by the Immigration and Customs Enforcement (ICE) officer who fatally shot ...

Secretary of War Hegseth announced that his department is "taking a sledgehammer to the oldest DEI program in the federal government—the 8(a) program." (Source: X @SecWar) On January 16, 2026, ...

SAN FRANCISCO, Jan 16 (Reuters) - More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical ...

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...